Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Colorado BioScience

16:02 EST 20th November 2017 | BioPortfolio

Here are the most relevant search results for "Colorado BioScience" found in our extensive news archives from over 250 global news sources.

More Information about Colorado BioScience on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Colorado BioScience for you to read. Along with our medical data and news we also list Colorado BioScience Clinical Trials, which are updated daily. BioPortfolio also has a large database of Colorado BioScience Companies for you to search.

Showing News Articles 1–25 of 82 from Colorado BioScience

Wednesday 15th November 2017

Ready for Retirees

How the Sector is Preparing for the State’s Shifting Demographics Colorado consistently ranks as a top destination for retirees. With Baby Boomers reaching retirement age at the rate of 10,000 per day, the population of Coloradoans older than 65 will increase from close to 500,000 in 2010 to more than 1.2 million by 2030. What will be the economic, social and health consequences of the o...

Monday 13th November 2017

Former Array Biopharma COO, Dr. David L. Snitman joins AmideBio Business Advisory Board

AmideBio LLC, a privately-held biopharmaceutical company, announced today that Dr. David L. Snitman has joined its business advisory board. Dr. Snitman has extensive experience with company financing as well as building strategic alliances with the pharmaceutical industry. He will be a huge asset to the company as it develops its pipeline of novel drugs targeting diabetes and ...

Thursday 9th November 2017

ImmunoMolecular Therapeutics Launches to Advance Innovative Immuno therapi es for Genetically Defined Type 1 Diabetes and Other Autoimmune Diseases

ImmunoMolecular Therapeutics (IM Therapeutics), a company developing personalized small molecule therapies for the treatment of genetically defined autoimmune diseases, today made its debut as a spinout from the Barbara Davis Center for Diabetes at the University of Colorado. IM Therapeutics was co-founded by Peter Gottlieb, M.D., Professor of Pediatrics and Medicine with tenu...

Tuesday 7th November 2017

TranS1: Innovative Products and Partnerships

Supporting Spine Surgery’s Invention Engine Minimally invasive spine surgery sounds like an oxymoron. But that’s precisely the goal at TranS1, headquartered in a restored Victorian home in Denver’s hip Highlands neighborhood. The company, led by CEO Jeff Schell, is focused on optimizing spine surgery while reducing patient trauma. TranS1 is accomplishing that goal with a growing li...

Tuesday 31st October 2017

Champions for Bioscience

Accelerating Industry Success through Advocacy The CBSA team leads advocacy efforts on behalf of the industry and our members. We work every day to create an innovation-friendly business environment. Our policy activities at the state and federal level focus on proactive and reactive legislation. Our commitment to strong connections with federal, state and local officials fosters a cultu...

Thursday 26th October 2017

Four Companies Win Their Share of $150,000 in Healthcare Shark-Tank Event

During the 2017 Prime Health Challenge, six healthcare technology startups pitched to representatives from 16 host institutions, including Kaiser Permanente, Metro Community Provider Network, AllHealth Network, Centura, UCHealth, and SCL Health. Over 500 audience members watched as each company competed for an opportunity to prove their solutions with Colorado healthcare institutions. ...

Tuesday 24th October 2017

‘It’s All About the Kids’

Children Inspire the Team at Silvergate Pharmaceuticals As a pharmacist managing some of the largest consumer pharmacies in the country, Frank Segrave saw a need. The majority of medications on his shelves—most of them in tablet or capsule form—were proportioned for adult dosages. To fill a prescription for a child, Segrave had to do what all pharmacists did: crush up the adult pill...

Friday 20th October 2017

DMC Biotechnologies, Inc. Awarded Competitive Grant from the U.S. Department of Agriculture National Institute of Food and Agriculture

DMC Biotechnologies, Inc. (www.dmcbio.com), an early-stage biotechnology company,has been awardeda U.S. Department of Agriculture National Institute of Food and Agriculture (USDA NIFA) Small Business Innovation Research (SBIR)Phase Igrantfor $100,000 to commercialize their proprietary high throughput metabolic engineering platform that enables the rapid development of ...

Wednesday 18th October 2017

Diversity Suits the C-Suite

At Biodesix, Female Executives ‘Shake Things Up’ to Drive Growth Anyone who works in bioscience knows there are few women in executive leadership roles. Although women come into the industry at the same rate as men, only one in four moves up to a C-level position and only one in 10 makes it to the board of directors, according to a recent study. Things are different at Boulder-bas...

Wednesday 11th October 2017

Collaborative by Nature

A Commitment to Working Together Supports Success There’s something different about Colorado. It’s more than our beautiful natural surroundings and abundant sunshine, favorable business climate and talented workforce. Companies and organizations share a commitment to working together and helping each other solve business challenges. “We know that how we work matters just as much...

Thursday 5th October 2017

Flagship Biosciences Provides Analytically Validated Tools to Assist in the Analysis of Summits PhaseOut DMD Clinical Trial

CLSI compliant analytically validated cTA™ tools for 2 duplex IHC assays presented at the 22nd annual meeting of the World Muscle Society Flagship Biosciences, Inc., the leading developer of quantitative tissue biomarker interpretations for clinical development of tissue-based diagnostics to drive clinical decisions for industry partners, presented today 2 analytically validated duplex ...

MBC Pharma Inc. Awarded a SBIR Phase II Grant to Further Develop a Novel Bone-Targeted Combination Treatment for Osteosarcoma

MBC Pharma Inc., a privately held biopharmaceutical company announced today, that it has been awarded an $2M Phase II Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health. MBC will use this 2-year grant to build upon the success of the Phase I grant—demonstration of in vivo efficacy in model systems of osteosarcoma. The new work will focus o...

Monday 2nd October 2017

Smart, Hard-Working and Happy

A Talented Workforce Powers Colorado’s Bioscience Industry Bright, passionate people make Colorado the ideal place for bioscience investment. Our state attracts leading talent from around the globe and boasts a dedicated, skilled workforce. Here are three reasons why our state’s people power attracts companies and investors from all over the world and makes bioscience products our...

Tuesday 26th September 2017

AlloSource Strives to Advance Healing

Colorado-based company balances unique mission with medical innovation AlloSource® began with a simple principle: to transform tragedy into possibility. Since that moment nearly 25 years ago, the company has transformed the possibilities of human tissue donation by finding new ways to help heal patients. The organization started as a local, Denver-based tissue bank and has grown into one o...

Monday 25th September 2017

dBMEDx Announces Supply Agreement with Direct Supply

dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has entered into a definitive supply agreement with Direct Supply®, the nation’s leading provider of equipment for the Senior Living market. Under the agreement, dBMEDx will integrate their proprietary bladder scanning technology into a new Direct Supply® device to create the first wir...

AmideBio Awarded NIH SBIR Phase 1 Grant to Study Novel Glucagon for the Treatment of Hyperinsulinism

AmideBio, LLC, a privately-held biopharmaceutical company, announced today that it has received a $338,387 Phase 1 Small Business Innovation Research (SBIR) grant from the National Institute of Health. Under the 2 year grant, AmideBio will develop and produce a series of solution-stable glucagons and test them both in vitro and in vivo with the goal of identifying a gl...

Friday 22nd September 2017

Cetya Therapeutics Announces STTR Grant Award

$240,000 Grant will allow evaluation of Cetya’s HDAC inhibitors for treatment of sickle cell disease Cetya Therapeutics, Inc. announces the award of a $240,000 Phase I STTR grant over a 12-month period to support the in vitro assessment of its HDAC inhibitors for upregulation of fetal hemoglobin as a potential treatment modality for sickle cell disease. Much research over the pa...

Tuesday 19th September 2017

i2 Pharmaceuticals: Boulder Based, Global Reach

Pioneering Research to Solve the Drug Discovery Puzzle Creating an effective drug to treat disease is a bit of a puzzle. Researchers shape many molecular pieces and fit them together into a therapeutic product to target diseased cells, such as cancerous ones, and shut them down. The scientific team at Boulder-based i2 Pharmaceuticals collaborates with drug companies and draws upon its ow...

Tuesday 12th September 2017

Quantifying Good Health in Colorado

Using Big Data to Improve Quality of Life Over the course of one person’s life, he or she may generate more than 12 terabytes of personal health data. If you were to store that information, it would be the same as archiving more than 6,000 hours of video. That data holds incredible insights on human health and how to improve it. In a state that consistently ranks as one of the ...

Tuesday 5th September 2017

Federal Labs in Colorado

Our State’s 33 Labs Make a $2.6 Billion Impact On any given day in Colorado, scientists at federal labs including the CDC in Fort Collins, NOAA in Boulder and NREL in Golden are studying diseases that are difficult to control, monitoring weather patterns and working on new ways to create and conserve energy. In all, 33 federal labs call Colorado home. It’s one of the largest concentratio...

Friday 1st September 2017

Clinicians and Patients Love OPTIONS App

Clinicians and Patients Love OPTIONSApp Preliminary Results from 2016 Prime Health Pilot The third place finalist from the 2016 Prime Health Challenge, Preventative Technology Solutions, released interim results of their clinical pilot of the OPTIONS App.The pilot measured physician and patient experience and is ongoing through mid-October. Early re...

Thursday 31st August 2017

Inocucor Expands Canada Sales and Distribution Reach

Montreal agri-tech company appoints V.P. of Canadian Sales, adds Ontario sales leader MONTREAL, Aug. 30, 2017 — Inocucor Technologies Inc., the agri-tech company that produces biological crop inputs for agriculture, will have greater capacity to serve Canada's farmers and greenhouse growers with the appointment of Jan Kral to Vice President of Sales–Canada, and Sean Chiki, formerly ...

Tuesday 29th August 2017

Mighty Oak Medical and OrthoPediatrics Team Up to Bring Pediatric-Friendly Spinal Navigation to Children’s Hospitals

Mighty Oak Medical and OrthoPediatrics recently announced a navigation partnership that can provide unsurpassed screw placement accuracy in the pediatric population. Mighty Oak Medical is the manufacturer of FIREFLY® Pedicle Screw Navigation Guides, which are 3D printed and patient-specific at each planned vertebral level. FIREFLY® Guides address the clear market need for a navigati...

Boettcher Foundation Helps Early-Career Scientists

Funding Propels Investigators’ Research The Boettcher Foundation launched its Webb-Waring Biomedical Research Awards with the goal of helping early-career investigators advance their research to a point where they would qualify for their first major federal grants. As part of our ongoing Breakthrough Profiles series, Colorado BioScience Association is pleased to highlight the Boettcher Fou...

Tuesday 22nd August 2017

RxREVU Modernizes Prescription Management

Digital Health Platform Informs Prescribing Decisions In the center of Denver’s construction chorus—a sign of the city’s recent economic boom—CEO Carm Huntress, and his team at RxRevu have their own renovation project underway. They want to overhaul how healthcare providers prescribe medication. Their digital health solution streamlines medication choice, reduces unintende...


Quick Search
Advertisement
 

News Quicklinks